Search Within

Benjamin Heath Durham

  1. "GSK Faculty"
Formats
  1. Journal Article (48)
  2. Meeting Abstract (42)
  3. Research Letter (2)
  4. Review (2)
  5. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (95)
  2. GSK Faculty (95)
  3. Department of Medicine (94)
  4. Executive Committee, Center for Hematologic Malignancies (94)
  5. Hematologic Malignancies, Division of (94)
  6. Tow Center for Developmental Oncology (TCDO) (84)

More Groups

People
  1. Omar Abdel-Wahab (83)
  2. Eli Diamond (54)
  3. Raajit Rampal (23)
  4. Ahmet Dogan (20)
  5. David Hyman (20)
  6. Young Rock Chung (18)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (11)
  4. 2022 (5)
  5. 2021 (7)
  6. 2020 (7)

More Years

Publications
  1. Blood (29)
  2. Pediatric Blood and Cancer (10)
  3. Cancer Discovery (4)
  4. Leukemia (4)
  5. Nature Medicine (4)
  6. Blood Advances (3)

More Publications

Publishers
  1. American Society of Hematology (32)
  2. Nature Publishing Group (16)
  3. Wiley Periodicals, Inc (10)
  4. American Association for Cancer Research (7)
  5. Cell Press (3)
  6. Ferrata Storti Foundation (3)

More Publishers

Results (95)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A gain-of-function p53-mutant oncogene promotes cell fate plasticity and myeloid leukemia through the pluripotency factor FOXH1
    Journal Article

    Loizou, E.; Banito, A.; Livshits, G.; Ho, Y. J.; Koche, R. P.; Sánchez-Rivera, F. J.; Mayle, A.; Chen, C. C.; Kinalis, S.; Bagger, F. O.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Molecular profiling of tumor tissue and plasma cell-free DNA from patients with non-langerhans cell histiocytosis
    Journal Article

    Janku, F.; Diamond, E. L.; Goodman, A. M.; Raghavan, V. K.; Barnes, T. G.; Kato, S.; Abdel-Wahab, O.; Durham, B. H.; Meric-Bernstam, F.; Kurzrock, R.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Efficacy of MEK inhibition in patients with histiocytic neoplasms
    Journal Article

    Diamond, E. L.; Durham, B. H.; Ulaner, G. A.; Drill, E.; Buthorn, J.; Ki, M.; Bitner, L.; Cho, H.; Young, R. J.; Francis, J. H.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Genomic analysis of C-group juvenile xanthogranuloma family lesions identifies novel kinase alterations and distinctive morphologic patterns
    Meeting Abstract

    Picarsic, J.; Alaggio, R.; Jaffe, R.; Diamond, E. L.; Durham, B. H.; Abdel-Wahab, O.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Histology of Rosai-Dorfman disease in a subset of patients with Erdheim-Chester disease: A distinct entity mainly driven by MAP2K1
    Meeting Abstract

    Razanamahery, J.; Diamond, E.; Cohen-Aubart, F.; Karl-Heinz, P.; Charlotte, F.; Helias-Rodzewicz, Z.; Dogan, A.; Abdel-Wahab, O.; Durham, B.; Ozkaya, N.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Progressive nodular histiocytosis. Report of a pediatric case
    Meeting Abstract

    Galluzzo, M. L.; Roibón, N. G.; Felizzia, G.; La Rosa, C. S.; Buján, M. M.; Braier, J.; Durham, B. H.; Abdel-Wahab, O.; Diamond, E. L.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Histology of Rosai-Dorfman disease in a subset of patients with Erdheim-Chester disease: A distinct entity mainly driven by MAP2K1
    Meeting Abstract

    Razanamahery, J.; Diamond, E. L.; Plate, K.; Charlotte, F.; Hélias-Rodzewicz, Z.; Dogan, A.; Abdel-Wahab, O. I.; Durham, B. H.; Ozkaya, N.; Amoura, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The role of microRNAs in the pathogenesis of Erdheim-Chester disease and their potential use as biomarkers for diagnosis and prognosis of the disease
    Meeting Abstract

    Weissman, R.; Pilar, N.; Durham, B. H.; Ki, M.; Mazor, R. D.; Abdel-Wahab, O. I.; Shomron, N.; Shpilberg, O.; Diamond, E. L.; Rokah, O.
    Blood (2018)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in sporadic and familial histiocytic neoplasms
    Meeting Abstract

    Durham, B. H.; Lopez-Rodrigo, E.; Abramson, D. H.; Picarsic, J.; Pastore, A.; Mandelker, D.; Walsh, M. F.; Arcila, M. E.; Ladanyi, M.; Solit, D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Single-agent dabrafenib for intracranial BRAFV600E-mutated histiocytosis
    Meeting Abstract

    Bhatia, A.; Ulaner, G.; Rampal, R.; Hyman, D. M.; Abdel-Wahab, O.; Durham, B.; Hajdenberg, J.; Ganzel, C.; Diamond, E.
    Neurology (2018)

    Fulltext@MSK | Save